Abstract
Leclercia adecarboxylata is being increasingly diagnosed as a causative agent of infection due to the availability of rapid molecular diagnostic techniques Few cases of bacteraemia in subjects with underlying medical conditions have been reported. We report a case of L. adecarboxylata bacteraemia in an immunocompromised patient with metabolic syndrome.
MeSH terms
-
Amoxicillin-Potassium Clavulanate Combination / therapeutic use
-
Bacteremia / diagnosis*
-
Bacteremia / microbiology*
-
Bacteremia / therapy
-
Body Mass Index
-
Debridement / methods
-
Diabetes Mellitus, Type 2 / complications
-
Enterobacteriaceae / isolation & purification*
-
Enterobacteriaceae Infections / complications
-
Enterobacteriaceae Infections / diagnosis*
-
Enterobacteriaceae Infections / therapy
-
Female
-
Humans
-
Hypertension / complications
-
Immunocompromised Host*
-
Leg / pathology
-
Metabolic Syndrome / complications*
-
Middle Aged
-
Risk Factors
-
Treatment Outcome
Substances
-
Amoxicillin-Potassium Clavulanate Combination